摘要:
Une méthode de traitement de la leucemie myéloïde consiste à administrer à une personne une quantité efficace d'un antagoniste contre le GM-CSF. De préférence, l'antagoniste est un anticorps monoclonal de blocage spécifique contre le GM-CSF humain, ou un fragment ou une composition de liaison dérivé de celui-ci.
摘要:
Un polypeptide dénommé H400 et l'acide nucléique qui l'encode sont décrits comme marqueurs spécifiques contre les cellules humaines activées. Lesdites cellules sont détectées immunochimiquement par des anticorps monoclonaux spécifiques contre le H400 ou ses fragments peptidiques immunogéniques. Les cellules T activées sont également détectées par des sondes d'acide nucléique dirigées vers l'ARN messager encodant la protéine H400.
摘要:
A cDNA clone is provided which encodes a human receptor for the Fc portion of immunoglobulin G. Soluble forms of the receptor may be useful in treating disorders associated with excessive immunoglobulin G production. Cells expressing membrane-bound forms of the receptor are useful in assays for immune complexes, elevated levels of which are associated with numerous disease states, including systemic lupus erythematosus (SLE) and rheumatoid arthritis.
摘要:
Human granulocyte-macrophage colony stimulating factor (GM-CSF) polypeptides are provided, as well as methods for synthesizing conformationally and antigenically neutral muteins. The disclosed GM-CSFs promote growth and development of various hematopoietic lineages, and may be useful in treating conditions involving depressed blood cell populations and/or depressed blood cell regeneration, such as myeloid hypoplasia, chronic infections, and hematopoiesis after bone marrow transplantation. The invention also includes a novel mammalian expression vector.
摘要:
Mutant murine interleukin-2 proteins (muteins) are provided. Muteins containing deletions and/or substitutions within the first 30 N-terminal amino acids are almost all biologically active. The frequence of biologically active mutants is much lower for deletions and/or substitutions in other regions of the native protein.
摘要:
Synthetic human interleukin-1α genes are provided whose codons are selected from those preferred by bacteria. High expression levels are obtained in an E. coli expression system for both native interleukin-1α and several mutant interleukin-1α's.
摘要:
Mammalian proteins and muteins thereof, designated interleukin-4s (IL-4s), are provided which exhibit both B cell growth factor activity and T cell growth factor activity. Compounds of the invention include native human and murine IL-4s, muteins thereof, and nucleic acids which are effectively homologous to disclosed cDNAs, and/or which are capable of coding for mammalian IL-4s and their muteins.
摘要:
Antibodies to mammalian Interleukin-4 and muteins are provided, especially to native human IL-4s, as well as peptides useful as antigens in their production. Nucleic acids are disclosed which are capable of coding for the mammalian IL-4s and their muteins.
摘要:
Antibodies to mammalian Interleukin-4 and muteins are provided, especially to native human IL-4s, as well as peptides useful as antigens in their production. Nucleic acids are disclosed which are capable of coding for the mammalian IL-4s and their muteins.